ArticleResearch and reports in urology2025
Retrospective Study on Ureteroscopic Lithotripsy in Patients with Ureteral Duplication: Clinical Characteristics and Treatment Outcomes.
Article in Research and reports in urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the clinical characteristics and treatment outcomes of ureteroscopic lithotripsy (URSL) in patients with ureteral duplication and urinary stones. Methods: This retrospective study analyzed 18 patients with ureteral duplication and urolithiasis who underwent URSL between January 2020 and December 2024. A control group of 200 patients with normal urinary anatomy who underwent URSL during the same period was randomly selected. Demographic data, clinical features, stone size and location, comorbidities, and surgical outcomes (operative time, postoperative hospital stay, and complications) were collected and compared between groups. Results: No significant differences were found in age, gender, or BMI between the two groups. The ureteral duplication group had a higher proportion of patients with a history of urinary stones. Stone location differed significantly, with fewer right-sided ureteral stones in the duplication group. Despite anatomical challenges, there were no significant differences in operative time, hospital stay, or complication rates between the groups. Conclusion: URSL is a safe and effective treatment for patients with ureteral duplication and urinary stones. Surgical outcomes are comparable to those in patients with normal urinary anatomy. Further research with larger sample sizes and long-term follow-up is needed to optimize diagnostic and therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.